Biocross 

e4Risk: a new, non genetic method to evaluate Alzheimer’s disease risk

OWNER

Cristina Perez (See Profile)

Sector

Biotech

Stage

Sales, licensing phases

Country

Spain

Provides information to the clinician of the patient's risk to develop AD, increasing the diagnostic accuracy

Easily implemented in the clinical practice of hospitals. Based on a simple technique to be used in a chemistry analyzer

Address one of the most important worldwide challenge: to built effective strategies of AD prevention and diagnosis

Strategies market niches: Clinical trials, Prevention strategies and Neurology patients with a cognitive impairment

This information is confidential, do not share or copy.

Under evaluation at least till: 30th September

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2019 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar